Bulletin
Investor Alert

New York Markets Open in:

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 21, 2021, 4:54 p.m.

/zigman2/quotes/203556943/composite

$

34.04

Change

0.00 0.00%

Volume

Volume 6,699

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Previous close

$ 34.21

$ 34.04

Change

-0.17 -0.50%

Day low

Day high

$33.80

$35.00

Open

52 week low

52 week high

$26.20

$68.40

Open

Steven L. Hoerter

Steven L. Hoerter occupies the position of President, Chief Executive Officer & Director at Deciphera Pharmaceuticals, Inc. and President, Director & Chief Executive Officer at Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.). Steven L. Hoerter is also on the board of Oric Pharmaceuticals, Inc.

In the past he held the position of Chief Commercial Officer at Agios Pharmaceuticals, Inc., Chief Commercial Officer & Executive VP of Clovis Oncology, Inc., Director-Pipeline Development at Genentech, Inc. and GM, Head-Sub-Saharan Africa & Indian Ocean Region at Roche Group.

Steven L. Hoerter received an undergraduate degree from Bucknell University, an MBA from the University of Tilburg and a graduate degree from Purdue University.

Transactions

Date Shares Transaction Value
03/18/2021 2,450   Derivative/Non-derivative trans. at $43.19 per share. 105,816
03/18/2021 700   Derivative/Non-derivative trans. at $42.39 per share. 29,673
01/21/2021 1,078   Derivative/Non-derivative trans. at $25.4 per share. 27,381
08/20/2020 187   Derivative/Non-derivative trans. at $25.4 per share. 4,749
07/20/2020 188   Derivative/Non-derivative trans. at $25.4 per share. 4,775
06/18/2020 187   Derivative/Non-derivative trans. at $25.4 per share. 4,749
05/28/2020 188   Derivative/Non-derivative trans. at $25.4 per share. 4,775
04/21/2020 187   Derivative/Non-derivative trans. at $25.4 per share. 4,749
03/19/2020 520   Derivative/Non-derivative trans. at $39.98 per share. 20,790
03/19/2020 2,164   Derivative/Non-derivative trans. at $39.22 per share. 84,873
03/19/2020 4,230   Derivative/Non-derivative trans. at $38.26 per share. 161,840
03/19/2020 1,012   Derivative/Non-derivative trans. at $36.88 per share. 37,323
03/19/2020 4,494   Derivative/Non-derivative trans. at $35.78 per share. 160,796
03/18/2020 2,250   Derivative/Non-derivative trans. at $25.4 per share. 57,150

Officers and Executives

Mr. Steven L. Hoerter
President, Chief Executive Officer & Director
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer
Mr. Eric Haltom
Senior Vice President-Clinical Operations
Mr. Daniel C. Martin
Chief Commercial Officer
Ms. Jennifer Robinson
Head-Investor Relations
Ms. Caroline Chevalier
Vice President-Human Resources
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Chairman
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Link to MarketWatch's Slice.